LifeMine raised an oversubscribed $188M Series E (plus a prior $75M Series D) to push LIFE-001 — a novel calcineurin-pathway immunosuppressant — toward Phase 2 kidney transplant studies, with ARCH among continuing backers.
Hadrian raised $1.37B at a ~$7.87B valuation to scale automated factories that make parts for submarines, aircraft, and vehicles — with a16z, Founders Fund, and Lux still in the syndicate.
Gravity’s $30.5M Series A (Lightspeed + Committed Capital) is a bet that AI chat needs a neutral ad exchange. Named logos exist. Revenue, spend, and take rates were not disclosed. Here is what that round actually tells you.
Grouped explainers for deals not covered in other early-August roundups — Horizon3, Aurelius, Avatar Robotics, Faye, Sapiom, and Buzz Solutions — with who-uses, why-now, and portfolio-fit angles.
Vertex Ventures SEA & India and Vertex Growth backed Singapore’s Acrab in a $130M Series B to commercialize GΞLIX 1 Agent Box — silicon + edge models + orchestration for agents.
A two-day cluster of megadeals — Valar Atomics, Base Power, HappyRobot, Volta, Decade, Multiplier, Yellow Card, and more — shows capital concentrating on powering AI and operationalizing agents.
